Related Experiment Video
Updated: May 23, 2026
10:03
Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery
Published on: November 5, 2019
Meningococcal B disease: assessment and management
1A Talent 4 Health Limited, Cheltenham. info@talent4health.co.uk
Nursing Standard (Royal College of Nursing (Great Britain) : 1987)
|April 10, 2012
Summary
Serogroup B meningococcal disease remains a significant threat in the UK. Research is progressing towards a preventive vaccine for this serious bacterial meningitis and septicaemia.
Area of Science:
- Microbiology
- Immunology
- Public Health
Background:
- Serogroup B meningococcal disease is a leading cause of bacterial meningitis and septicaemia in the UK.
- Currently, no vaccine is available to prevent this specific serogroup of meningococcal disease.
- Meningococcal disease poses a significant public health challenge due to its potential for rapid progression and severe outcomes.
Purpose of the Study:
- To outline the characteristics of meningococcal disease.
- To highlight National Institute for Health and Clinical Excellence (NICE) guidance for disease recognition and management.
- To provide an update on the development of a preventive vaccine for Serogroup B.
Main Methods:
- Literature review on meningococcal disease epidemiology and clinical presentation.
- Analysis of current National Institute for Health and Clinical Excellence (NICE) guidelines.
- Review of recent research and development in meningococcal serogroup B vaccine technology.
Main Results:
- Serogroup B meningococcal disease is the primary remaining cause of bacterial meningitis and septicaemia in the UK.
- NICE provides updated guidance for healthcare professionals on recognizing and managing the disease in various care settings.
- Progress is being made in the development of a vaccine against Serogroup B.
Conclusions:
- Effective recognition and management of meningococcal disease are crucial for patient outcomes.
- The development of a Serogroup B vaccine is a priority for public health in the UK.
- Continued research and implementation of clinical guidelines are essential to combat meningococcal disease.
Related Concept Videos
01:22Bacterial Meningitis I: Introduction
Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...
01:26Bacterial Meningitis II: Pathophysiology
Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...
01:18Viral Meningitis
Viral meningitis is the most common form of meningitis and is often referred to as aseptic meningitis to indicate the absence of bacterial involvement. It is generally milder than bacterial meningitis, with symptoms including fever, headache, stiff neck, drowsiness, nausea, photophobia, and vomiting. Rarely, more severe manifestations or death may occur. Common causative agents include enteroviruses, particularly coxsackie A and B viruses and echoviruses, all members of the Enterovirus genus...
01:21Rheumatic Heart Disease III: Medical Management
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
01:26Mitral Stenosis III: Medical Management
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
01:20Rheumatic Heart Disease IV: Nursing Management
AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...